Avantor (AVTR) Set to Announce Quarterly Earnings on Thursday | MarketBeat

2022-07-24 06:09:00 By : Ms. Dennise Wang

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Avantor (NYSE:AVTR - Get Rating) will be posting its quarterly earnings results after the market closes on Thursday, July 28th. Analysts expect Avantor to post earnings of $0.38 per share for the quarter. Individual interested in registering for the company's earnings conference call can do so using this link.

Avantor (NYSE:AVTR - Get Rating) last issued its quarterly earnings data on Thursday, April 28th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.93 billion. Avantor had a net margin of 7.72% and a return on equity of 32.17%. The business's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.35 EPS. On average, analysts expect Avantor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year. Avantor Price Performance

Avantor stock opened at $29.32 on Thursday. The firm has a market cap of $17.90 billion, a PE ratio of 32.94, a price-to-earnings-growth ratio of 0.60 and a beta of 1.44. Avantor has a 52-week low of $27.51 and a 52-week high of $44.37. The company has a quick ratio of 1.18, a current ratio of 1.80 and a debt-to-equity ratio of 2.03. The company's 50 day moving average is $30.93 and its two-hundred day moving average is $33.12. Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Evercore ISI lowered their price objective on shares of Avantor from $44.00 to $42.00 and set an "outperform" rating on the stock in a research report on Monday, April 4th. Citigroup downgraded shares of Avantor from a "buy" rating to a "neutral" rating and dropped their target price for the company from $48.00 to $38.00 in a report on Monday, April 4th. TheStreet upgraded shares of Avantor from a "c" rating to a "b-" rating in a report on Thursday, May 19th. Raymond James lowered their price target on shares of Avantor from $43.00 to $40.00 and set an "outperform" rating for the company in a report on Monday, April 18th. Finally, Wells Fargo & Company lowered their target price on shares of Avantor from $42.00 to $33.00 and set an "overweight" rating for the company in a report on Monday, April 25th. One research analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Avantor has a consensus rating of "Moderate Buy" and a consensus target price of $42.53.Insider Activity

In other Avantor news, EVP Frederic Vanderhaegen sold 39,000 shares of the business's stock in a transaction that occurred on Monday, May 23rd. The stock was sold at an average price of $31.61, for a total transaction of $1,232,790.00. Following the transaction, the executive vice president now owns 126,764 shares of the company's stock, valued at approximately $4,007,010.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Frederic Vanderhaegen sold 39,000 shares of the business's stock in a transaction on Monday, May 23rd. The stock was sold at an average price of $31.61, for a total value of $1,232,790.00. Following the completion of the sale, the executive vice president now directly owns 126,764 shares in the company, valued at approximately $4,007,010.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Gerard Brophy sold 19,603 shares of the business's stock in a transaction on Friday, May 20th. The shares were sold at an average price of $31.27, for a total value of $612,985.81. Following the completion of the sale, the executive vice president now owns 96,935 shares of the company's stock, valued at $3,031,157.45. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders. Institutional Investors Weigh In On Avantor

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Robeco Schweiz AG lifted its holdings in shares of Avantor by 23.5% in the first quarter. Robeco Schweiz AG now owns 5,619,400 shares of the company's stock valued at $190,048,000 after purchasing an additional 1,067,804 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Avantor by 0.9% in the first quarter. Vanguard Group Inc. now owns 50,759,035 shares of the company's stock valued at $1,716,671,000 after purchasing an additional 439,147 shares in the last quarter. United Capital Financial Advisers LLC purchased a new position in shares of Avantor in the first quarter valued at $13,814,000. The Manufacturers Life Insurance Company grew its position in shares of Avantor by 2,120.6% in the first quarter. The Manufacturers Life Insurance Company now owns 231,589 shares of the company's stock valued at $7,952,000 after purchasing an additional 221,160 shares in the last quarter. Finally, Eaton Vance Management grew its position in shares of Avantor by 36.9% in the first quarter. Eaton Vance Management now owns 497,827 shares of the company's stock valued at $16,837,000 after purchasing an additional 134,200 shares in the last quarter. Institutional investors and hedge funds own 93.24% of the company's stock. About Avantor (Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.See AlsoGet a free copy of the StockNews.com research report on Avantor (AVTR)These 3 Mega Caps are Bear Market BuysHow Low Can DocuSign Stock Go?The Top-Rated Consumer Defensive Stocks With Yield Above 3.5% JB Hunt's Results Beat Forecasts As Transport Industry Continues To Enjoy Strong Results.Need Yield? Energy Transfer LP Has It And More 

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

In this episode, Kate chats with regular guest Rob Isbitts, who, as always, debunks some traditional investing ideas, such as “buy the dip” and only going long while the market is in rally mode.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.

/body>